Neuromedical's injunction against NeoPath blocked:
This article was originally published in Clinica
Executive Summary
NeoPath has won its first courtroom battle concerning a threatened injunction by Neuromedical Systems. The April 1997 action from Neuromedical alleged patent infringement and demanded that NeoPath cease manufacture, sales and expansion of use of its AutoPap 300 QC System. It was thrown out by The US District Court last month. The Redmond, Washington-based NeoPath says that it will vigorously defend the action.